Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma

We have previously reported that Cezanne could be a prognostic biomarker for survival in hepatocellular carcinoma (HCC) patients. However, the role of Cezanne genes in HCC cells and its response to postoperative adjuvant transcatheter arterial chemoembolization (TACE) in HCC patients remains unknown...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jia-hong, Zhong, Xiao-ping, Zhang, Yong-fa, Wu, Xiao-liang, Li, Shao-hua, Jian, Pei-en, Ling, Yi-hong, Shi, Ming, Chen, Min-shan, Wei, Wei, Guo, Rong-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636974/
https://www.ncbi.nlm.nih.gov/pubmed/28880268
http://dx.doi.org/10.1038/cddis.2017.428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636974/
https://www.ncbi.nlm.nih.gov/pubmed/28880268
http://dx.doi.org/10.1038/cddis.2017.428

Ejemplares similares